Why is Indo US Bio-Tech falling/rising?

As of 31-Jul, Indo US Bio-Tech Ltd is experiencing a price increase, currently at Rs 175.20, which reflects a rise of Rs 5.75 or 3.39%. The stock has shown strong performance today, outperforming its sector by 3.71% and achieving a consecutive gain over the last two days, with an overall return of 8.55% during this period. The stock opened with a gain of 2.04% and reached an intraday high of Rs 177.9. Despite this positive movement, there is a notable decline in investor participation, as the delivery volume has decreased by 48.36% compared to the five-day average. The company has demonstrated high management efficiency, a strong ability to service debt, and healthy long-term growth, with significant increases in both profit after tax and net sales over the last six months, which likely contribute to the stock's upward momentum.
In the broader market context, Indo US Bio-Tech's short-term return of 3.15% over the past week stands in stark contrast to the Sensex, which has declined by 1.22% during the same period. This indicates that the stock is not only rising but is also gaining traction against the broader market trend. Over the past month, the stock has increased by 14.66%, while the Sensex has fallen by 3.00%, further highlighting its relative strength. Despite a year-to-date decline of 44.38%, the stock's impressive performance over the last three and five years, with returns of 288.25% and 836.07% respectively, suggests a potential recovery phase that investors may be responding to positively.